{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T12:12:05Z","timestamp":1789560725275,"version":"build-2803163510"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T00:00:00Z","timestamp":1677456000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T00:00:00Z","timestamp":1677456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["IPR-144157"],"award-info":[{"award-number":["IPR-144157"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["IPR-144157"],"award-info":[{"award-number":["IPR-144157"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Vaccines"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Schistosomiasis threatens hundreds of millions of people worldwide. The larval stage of <jats:italic>Schistosoma mansoni<\/jats:italic> migrates through the lung and adult worms reside adjacent to the colonic mucosa. Several candidate vaccines are in preclinical development, but none is designed to elicit both systemic and mucosal responses. We have repurposed an attenuated <jats:italic>Salmonella enterica<\/jats:italic> Typhimurium strain (YS1646) to express Cathepsin B (CatB), a digestive enzyme important for the juvenile and adult stages of the <jats:italic>S. mansoni<\/jats:italic> life cycle. Previous studies have demonstrated the prophylactic and therapeutic efficacy of our plasmid-based vaccine. Here, we have generated chromosomally integrated (CI) YS1646 strains that express CatB to produce a viable candidate vaccine for eventual human use (stability, no antibiotic resistance). 6\u20138-week-old C57BL\/6 mice were vaccinated in a multimodal oral (PO) and intramuscular (IM) regimen, and then sacrificed 3 weeks later. The PO\u2009+\u2009IM group had significantly higher anti-CatB IgG titers with greater avidity and mounted significant intestinal anti-CatB IgA responses compared to PBS control mice (all <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.0001). Multimodal vaccination generated balanced T<jats:sub>H<\/jats:sub>1\/T<jats:sub>H<\/jats:sub>2 humoral and cellular immune responses. Production of IFN\u03b3 by both CD4<jats:sup>+<\/jats:sup> and CD8<jats:sup>+<\/jats:sup> T cells was confirmed by flow cytometry (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.0001 &amp; <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.01). Multimodal vaccination reduced worm burden by 80.4%, hepatic egg counts by 75.2%, and intestinal egg burden by 78.4% (all <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.0001). A stable and safe vaccine that has both prophylactic and therapeutic activity would be ideal for use in conjunction with praziquantel mass treatment campaigns.<\/jats:p>","DOI":"10.1038\/s41541-023-00599-w","type":"journal-article","created":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T11:04:30Z","timestamp":1677495870000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Salmonella Typhimurium expressing chromosomally integrated Schistosoma mansoni Cathepsin B protects against schistosomiasis in mice"],"prefix":"10.1038","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4092-7172","authenticated-orcid":false,"given":"Adam S.","family":"Hassan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Houle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia","family":"Labrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0874-7251","authenticated-orcid":false,"given":"Dilhan J.","family":"Perera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles M.","family":"Dozois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3251-958X","authenticated-orcid":false,"given":"Brian J.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9012-4212","authenticated-orcid":false,"given":"Momar","family":"Ndao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,27]]},"reference":[{"key":"599_CR1","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s00281-020-00789-x","volume":"42","author":"DP McManus","year":"2020","unstructured":"McManus, D. P. et al. Schistosomiasis\u2014from immunopathology to vaccines. Semin. Immunopathol. 42, 355\u2013371 (2020).","journal-title":"Semin. Immunopathol."},{"key":"599_CR2","doi-asserted-by":"publisher","first-page":"e330","DOI":"10.1016\/S2542-5196(20)30129-7","volume":"4","author":"E L\u00e9ger","year":"2020","unstructured":"L\u00e9ger, E. et al. Prevalence and distribution of schistosomiasis in human, livestock, and snail populations in northern Senegal: a One Health epidemiological study of a multi-host system. Lancet Planet. Heal. 4, e330 (2020).","journal-title":"Lancet Planet. Heal."},{"key":"599_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13071-021-05121-6","volume":"15","author":"SCM Trienekens","year":"2022","unstructured":"Trienekens, S. C. M. et al. Variation in water contact behaviour and risk of Schistosoma mansoni (re)infection among Ugandan school-aged children in an area with persistent high endemicity. Parasit. Vectors 15, 15 (2022).","journal-title":"Parasit. Vectors"},{"key":"599_CR4","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.molbiopara.2014.06.002","volume":"195","author":"D Cioli","year":"2014","unstructured":"Cioli, D., Pica-Mattoccia, L., Basso, A. & Guidi, A. Schistosomiasis control: praziquantel forever? Mol. Biochem. Parasitol. 195, 23\u201329 (2014).","journal-title":"Mol. Biochem. Parasitol."},{"key":"599_CR5","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1590\/S0074-02762011000200006","volume":"106","author":"FFB Couto","year":"2011","unstructured":"Couto, F. F. B. et al. Schistosoma mansoni: a method for inducing resistance to praziquantel using infected Biomphalaria glabrata snails. Mem. Inst. Oswaldo Cruz 106, 153\u2013157 (2011).","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"599_CR6","first-page":"589","volume":"32","author":"MM Ismail","year":"2002","unstructured":"Ismail, M. M., Farghaly, A. M., Dyab, A. K., Afify, H. A. & el-Shafei, M. A. Resistance to praziquantel, effect of drug pressure and stability test. J. Egypt. Soc. Parasitol. 32, 589\u2013600 (2002).","journal-title":"J. Egypt. Soc. Parasitol."},{"key":"599_CR7","doi-asserted-by":"publisher","unstructured":"Molehin, A. J., Mcmanus, D. P. & You, H. Vaccines for human Schistosomiasis: recent progress, new developments and future prospects. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms23042255 (2022).","DOI":"10.3390\/ijms23042255"},{"key":"599_CR8","doi-asserted-by":"publisher","first-page":"e0007490","DOI":"10.1371\/journal.pntd.0007490","volume":"13","author":"AS Hassan","year":"2019","unstructured":"Hassan, A. S., Zelt, N. H., Perera, D. J., Ndao, M. & Ward, B. J. Vaccination against the digestive enzyme cathepsin B using a YS1646 Salmonella enterica Typhimurium vector provides almost complete protection against Schistosoma mansoni challenge in a mouse model. PLoS Negl. Trop. Dis. 13, e0007490 (2019).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"599_CR9","doi-asserted-by":"publisher","first-page":"5580","DOI":"10.1016\/j.vaccine.2021.08.031","volume":"39","author":"AS Hassan","year":"2021","unstructured":"Hassan, A. S., Perera, D. J., Ward, B. J. & Ndao, M. Therapeutic activity of a Salmonella-vectored Schistosoma mansoni vaccine in a mouse model of chronic infection. Vaccine 39, 5580\u20135588 (2021).","journal-title":"Vaccine"},{"key":"599_CR10","doi-asserted-by":"publisher","first-page":"541268","DOI":"10.1155\/2012\/541268","volume":"2012","author":"CT Fonseca","year":"2012","unstructured":"Fonseca, C. T., Braz Figueiredo Carvalho, G., Carvalho Alves, C. & De Melo, T. T. Schistosoma tegument proteins in vaccine and diagnosis development: an update. J. Parasitol. Res. 2012, 541268 (2012).","journal-title":"J. Parasitol. Res."},{"key":"599_CR11","doi-asserted-by":"publisher","first-page":"6001","DOI":"10.1128\/AEM.00986-12","volume":"78","author":"S Cr\u00e9pin","year":"2012","unstructured":"Cr\u00e9pin, S., Harel, S. & Dozois, C. M. Chromosomal complementation using Tn7 transposon vectors in enterobacteriaceae. Appl. Environ. Microbiol. 78, 6001\u20136008 (2012).","journal-title":"Appl. Environ. Microbiol."},{"key":"599_CR12","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/978-3-030-18616-6_3","volume":"1154","author":"PT LoVerde","year":"2019","unstructured":"LoVerde, P. T. Schistosomiasis. Adv. Exp. Med. Biol. 1154, 45\u201370 (2019).","journal-title":"Adv. Exp. Med. Biol."},{"key":"599_CR13","doi-asserted-by":"publisher","first-page":"159","DOI":"10.12688\/wellcomeopenres.15487.1","volume":"4","author":"C Crosnier","year":"2019","unstructured":"Crosnier, C. et al. Systematic screening of 96Schistosoma mansoni cell-surface and secreted antigens does not identify any strongly protective vaccine candidates in a mouse model of infection. Wellcome Open Res. 4, 159 (2019).","journal-title":"Wellcome Open Res."},{"key":"599_CR14","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S0166-6851(03)00194-4","volume":"131","author":"M Sajid","year":"2003","unstructured":"Sajid, M. et al. Functional expression and characterization of Schistosoma mansoni cathepsin B and its trans-activation by an endogenous asparaginyl endopeptidase. Mol. Biochem. Parasitol. 131, 65\u201375 (2003).","journal-title":"Mol. Biochem. Parasitol."},{"key":"599_CR15","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.molbiopara.2005.06.007","volume":"143","author":"JM Correnti","year":"2005","unstructured":"Correnti, J. M., Brindley, P. J. & Pearce, E. J. Long-term suppression of cathepsin B levels by RNA interference retards schistosome growth. Mol. Biochem. Parasitol. 143, 209\u2013215 (2005).","journal-title":"Mol. Biochem. Parasitol."},{"key":"599_CR16","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s004360050060","volume":"82","author":"YL Li","year":"1996","unstructured":"Li, Y. L. et al. Circulating antigens in schistosomiasis: detection of 31\/32-kDa proteins in sera from patients infected with Schistosoma japonicum, S. mansoni, S. haematobium, or S. intercalatum. Parasitol. Res. 82, 14\u201318 (1996).","journal-title":"Parasitol. Res."},{"key":"599_CR17","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.vaccine.2014.11.016","volume":"33","author":"A Ricciardi","year":"2015","unstructured":"Ricciardi, A., Dalton, J. P. & Ndao, M. Evaluation of the immune response and protective efficacy of Schistosoma mansoni cathepsin B in mice using CpG dinucleotides as adjuvant. Vaccine 33, 346\u2013353 (2015).","journal-title":"Vaccine"},{"key":"599_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-016-1444-z","volume":"16","author":"A Ricciardi","year":"2016","unstructured":"Ricciardi, A., Visitsunthorn, K., Dalton, J. P. & Ndao, M. A vaccine consisting of Schistosoma mansoni cathepsin B formulated in Montanide ISA 720 VG induces high level protection against murine schistosomiasis. BMC Infect. Dis. 16, 112 (2016).","journal-title":"BMC Infect. Dis."},{"key":"599_CR19","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.3389\/fimmu.2020.605288","volume":"11","author":"DJ Perera","year":"2020","unstructured":"Perera, D. J. et al. Adjuvanted Schistosoma mansoni-cathepsin B with sulfated lactosyl archaeol archaeosomes or AddaVaxTM provides protection in a pre-clinical schistosomiasis model. Front. Immunol. 11, 2990 (2020).","journal-title":"Front. Immunol."},{"key":"599_CR20","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0169-4758(97)01207-6","volume":"14","author":"VR Bergquist","year":"1998","unstructured":"Bergquist, V. R. & Colley, D. G. Schistosomiasis vaccine:research to development. Parasitol. Today 14, 99\u2013104 (1998).","journal-title":"Parasitol. Today"},{"key":"599_CR21","doi-asserted-by":"crossref","unstructured":"Mo, A. X. & Colley, D. G. Workshop report: schistosomiasis vaccine clinical development and product characteristics. Vaccine 34, 995\u20131001 (2016).","DOI":"10.1016\/j.vaccine.2015.12.032"},{"key":"599_CR22","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1475-2859-4-26","volume":"4","author":"J Glenting","year":"2005","unstructured":"Glenting, J. & Wessels, S. Ensuring safety of DNA vaccines. Microb. Cell Fact. 4, 26 (2005).","journal-title":"Microb. Cell Fact."},{"key":"599_CR23","first-page":"27","volume":"6","author":"V Yurina","year":"2018","unstructured":"Yurina, V. Live bacterial vectors\u2014A promising DNA vaccine delivery system. Med. Sci. 6, 27 (2018).","journal-title":"Med. Sci."},{"key":"599_CR24","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.tibtech.2013.06.001","volume":"31","author":"PH Oliveira","year":"2013","unstructured":"Oliveira, P. H. & Mairhofer, J. Marker-free plasmids for biotechnological applications - implications and perspectives. Trends Biotechnol. 31, 539\u2013547 (2013).","journal-title":"Trends Biotechnol."},{"key":"599_CR25","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1046\/j.1365-2958.2003.03843.x","volume":"51","author":"SM Kwong","year":"2004","unstructured":"Kwong, S. M., Skurray, R. A. & Firth, N. Staphylococcus aureus multiresistance plasmid pSK41: analysis of the replication region, initiator protein binding and antisense RNA regulation. Mol. Microbiol. 51, 497\u2013509 (2004).","journal-title":"Mol. Microbiol."},{"key":"599_CR26","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1046\/j.1365-2958.1998.01012.x","volume":"29","author":"D Summers","year":"1998","unstructured":"Summers, D. Timing, self-control and a sense of direction are the secrets of multicopy plasmid stability. Mol. Microbiol. 29, 1137\u20131145 (1998).","journal-title":"Mol. Microbiol."},{"key":"599_CR27","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1038\/mt.2011.182","volume":"19","author":"G Vandermeulen","year":"2011","unstructured":"Vandermeulen, G., Marie, C., Scherman, D. & Pr\u00e9at, V. New generation of plasmid backbones devoid of antibiotic resistance marker for gene therapy trials. Mol. Ther. 19, 1942 (2011).","journal-title":"Mol. Ther."},{"key":"599_CR28","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/35099006","volume":"2","author":"JE Peters","year":"2001","unstructured":"Peters, J. E. & Craig, N. L. Tn7: smarter than we thought. Nat. Rev. Mol. Cell Biol. 2, 806\u2013814 (2001).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"599_CR29","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s00203-016-1212-x","volume":"198","author":"AM Bennett","year":"2016","unstructured":"Bennett, A. M., Shippy, D. C., Eakley, N., Okwumabua, O. & Fadl, A. A. Functional characterization of glucosamine-6-phosphate synthase (GlmS) in Salmonella enterica serovar Enteritidis. Arch. Microbiol. 198, 541\u2013549 (2016).","journal-title":"Arch. Microbiol."},{"key":"599_CR30","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.3390\/pathogens10101299","volume":"10","author":"N Foster","year":"2021","unstructured":"Foster, N. et al. Revisiting persistent Salmonella infection and the carrier state: what do we know? Pathogens 10, 1299 (2021).","journal-title":"Pathogens"},{"key":"599_CR31","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1126\/science.282.5396.2085","volume":"282","author":"A Poltorak","year":"1998","unstructured":"Poltorak, A. et al. Defective LPS signaling in C3H\/HeJ and C57BL\/10ScCr mice: mutations in Tlr4 gene. Science 282, 2085\u20132088 (1998).","journal-title":"Science"},{"key":"599_CR32","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.micpath.2018.03.016","volume":"118","author":"M Makvandi","year":"2018","unstructured":"Makvandi, M. et al. Expression of Salmonella typhimurium and Escherichia coli flagellin protein and its functional characterization as an adjuvant. Microb. Pathog. 118, 87\u201390 (2018).","journal-title":"Microb. Pathog."},{"key":"599_CR33","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/35074106","volume":"410","author":"F Hayashi","year":"2001","unstructured":"Hayashi, F. et al. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 410, 1099\u20131103 (2001).","journal-title":"Nature"},{"key":"599_CR34","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1200\/JCO.2002.20.1.142","volume":"20","author":"JF Toso","year":"2002","unstructured":"Toso, J. F. et al. Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma. J. Clin. Oncol. 20, 142\u2013152 (2002).","journal-title":"J. Clin. Oncol."},{"key":"599_CR35","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1159\/000100515","volume":"53","author":"I Gentschev","year":"2007","unstructured":"Gentschev, I. et al. Vivotif-a \u2018magic shield\u2019 for protection against typhoid fever and delivery of heterologous antigens. Chemotherapy 53, 177\u2013180 (2007).","journal-title":"Chemotherapy"},{"key":"599_CR36","doi-asserted-by":"publisher","first-page":"e1313","DOI":"10.1371\/journal.pntd.0001313","volume":"5","author":"G Chen","year":"2011","unstructured":"Chen, G. et al. Oral delivery of the Sj23LHD-GST antigen by Salmonella typhimurium type III secretion system protects against Schistosoma japonicum infection in mice. PLoS Negl. Trop. Dis. 5, e1313 (2011).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"599_CR37","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.cimid.2012.09.006","volume":"36","author":"J Ding","year":"2013","unstructured":"Ding, J. et al. Immune responses to a recombinant attenuated Salmonella typhimurium strain expressing a Taenia solium oncosphere antigen TSOL18. Comp. Immunol. Microbiol. Infect. Dis. 36, 17\u201323 (2013).","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"key":"599_CR38","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.exppara.2011.08.013","volume":"129","author":"EN Pompa-Mera","year":"2011","unstructured":"Pompa-Mera, E. N. et al. Trichinella spiralis: intranasal immunization with attenuated Salmonella enterica Carrying a gp43 antigen-derived 30mer epitope elicits protection in BALB\/c mice. Exp. Parasitol. 129, 393\u2013401 (2011).","journal-title":"Exp. Parasitol."},{"key":"599_CR39","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s13258-020-00918-8","volume":"42","author":"AMP dos Santos","year":"2020","unstructured":"dos Santos, A. M. P., Ferrari, R. G. & Conte-Junior, C. A. Type three secretion system in Salmonella Typhimurium: the key to infection. Genes Genom. 42, 495\u2013506 (2020).","journal-title":"Genes Genom."},{"key":"599_CR40","doi-asserted-by":"publisher","first-page":"3687","DOI":"10.1007\/s00018-011-0841-0","volume":"68","author":"CV Srikanth","year":"2011","unstructured":"Srikanth, C. V., Mercado-Lubo, R., Hallstrom, K. & McCormick, B. A. Salmonella effector proteins and host-cell responses. Cell. Mol. Life Sci. 68, 3687 (2011).","journal-title":"Cell. Mol. Life Sci."},{"key":"599_CR41","doi-asserted-by":"publisher","first-page":"e0003925","DOI":"10.1371\/journal.pntd.0003925","volume":"9","author":"X-H Li","year":"2015","unstructured":"Li, X.-H. et al. Evidence that rhesus macaques self-cure from a Schistosoma japonicum infection by disrupting worm esophageal function: a new route to an effective vaccine? PLoS Negl. Trop. Dis. 9, e0003925 (2015).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"599_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-021-26497-0","volume":"12","author":"MS Amaral","year":"2021","unstructured":"Amaral, M. S. et al. Rhesus macaques self-curing from a schistosome infection can display complete immunity to challenge. Nat. Commun. 12, 1\u201317 (2021).","journal-title":"Nat. Commun."},{"key":"599_CR43","doi-asserted-by":"publisher","first-page":"e290","DOI":"10.1371\/journal.pntd.0000290","volume":"2","author":"RA Wilson","year":"2008","unstructured":"Wilson, R. A. et al. Elimination of Schistosoma mansoni adult worms by rhesus macaques: basis for a therapeutic vaccine? PLoS Negl. Trop. Dis. 2, e290 (2008).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"599_CR44","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/0014-4894(82)90092-3","volume":"53","author":"BJ Bogitsh","year":"1982","unstructured":"Bogitsh, B. J. Schistosoma mansoni: cytochemistry and morphology of the gastrodermal golgi apparatus. Exp. Parasitol. 53, 57\u201367 (1982).","journal-title":"Exp. Parasitol."},{"key":"599_CR45","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1017\/S0022149X00028066","volume":"58","author":"J Clarkson","year":"1984","unstructured":"Clarkson, J. & Erasmus, D. A. Schistosoma mansoni: an in vivo study of drug-induced autophagy in the gastrodermis. J. Helminthol. 58, 59\u201368 (1984).","journal-title":"J. Helminthol."},{"key":"599_CR46","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.ijpara.2020.11.011","volume":"51","author":"MN Mughal","year":"2021","unstructured":"Mughal, M. N., Grevelding, C. G. & Haeberlein, S. First insights into the autophagy machinery of adult Schistosoma mansoni. Int. J. Parasitol. 51, 571\u2013585 (2021).","journal-title":"Int. J. Parasitol."},{"key":"599_CR47","doi-asserted-by":"publisher","first-page":"104036","DOI":"10.1016\/j.ebiom.2022.104036","volume":"80","author":"DJ Perera","year":"2022","unstructured":"Perera, D. J. et al. A low dose adenovirus vectored vaccine expressing Schistosoma mansoni cathepsin B protects from intestinal schistosomiasis in mice. eBioMedicine 80, 104036 (2022).","journal-title":"eBioMedicine"},{"key":"599_CR48","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.3389\/fimmu.2018.01710","volume":"9","author":"A Ricciardi","year":"2018","unstructured":"Ricciardi, A., Zelt, N. H., Visitsunthorn, K., Dalton, J. P. & Ndao, M. Immune mechanisms involved in schistosoma mansoni-Cathepsin B vaccine induced protection in mice. Front. Immunol. 9, 1710 (2018).","journal-title":"Front. Immunol."},{"key":"599_CR49","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/pim.12091","volume":"36","author":"TT de Melo","year":"2014","unstructured":"de Melo, T. T., de Sena, I. C., Araujo, N. & Fonseca, C. T. Antibodies are involved in the protective immunity induced in mice by Schistosoma mansoni schistosomula tegument (Smteg) immunization. Parasite Immunol. 36, 107\u2013111 (2014).","journal-title":"Parasite Immunol."},{"key":"599_CR50","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/978-1-4684-5344-7_82","volume":"216A","author":"JE Crabtree","year":"1987","unstructured":"Crabtree, J. E. & Wilson, R. A. Pulmonary cellular reactions to Schistosoma mansoni schistosomula in normal and vaccinated mice. Adv. Exp. Med. Biol. 216A, 701\u2013707 (1987).","journal-title":"Adv. Exp. Med. Biol."},{"key":"599_CR51","doi-asserted-by":"publisher","first-page":"527","DOI":"10.4049\/jimmunol.150.2.527","volume":"150","author":"JM Grzych","year":"1993","unstructured":"Grzych, J. M. et al. IgA antibodies to a protective antigen in human Schistosomiasis mansoni. J. Immunol. 150, 527\u2013535 (1993).","journal-title":"J. Immunol."},{"key":"599_CR52","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1017\/S0031182000066890","volume":"82","author":"A Dessein","year":"1981","unstructured":"Dessein, A. et al. Immune evasion by Schistosoma mansoni: loss of susceptibility to antibody or complement-dependent eosinophil attack by schistosomula cultured in medium free of macromolecules. Parasitology 82, 357\u2013374 (1981).","journal-title":"Parasitology"},{"key":"599_CR53","doi-asserted-by":"publisher","first-page":"104","DOI":"10.4269\/ajtmh.1984.33.104","volume":"33","author":"EC Jong","year":"1984","unstructured":"Jong, E. C., Chi, E. Y. & Klebanoff, S. J. Human neutrophil-mediated killing of schistosomula of Schistosoma mansoni: augmentation by schistosomal binding of eosinophil peroxidase. Am. J. Trop. Med. Hyg. 33, 104\u2013115 (1984).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"599_CR54","first-page":"380","volume":"120","author":"JP Caulfield","year":"1985","unstructured":"Caulfield, J. P., Lenzi, H. L., Elsas, P. & Dessein, A. J. Ultrastructure of the attack of eosinophils stimulated by blood mononuclear cell products on schistosomula of Schistosoma mansoni. Am. J. Pathol. 120, 380\u2013390 (1985).","journal-title":"Am. J. Pathol."},{"key":"599_CR55","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.4049\/jimmunol.142.7.2393","volume":"142","author":"RI Abu-Ghazaleh","year":"1989","unstructured":"Abu-Ghazaleh, R. I., Fujisawa, T., Mestecky, J., Kyle, R. A. & Gleich, G. J. IgA-induced eosinophil degranulation. J. Immunol. 142, 2393\u20132400 (1989).","journal-title":"J. Immunol."},{"key":"599_CR56","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/mi.2015.2","volume":"8","author":"J Travers","year":"2015","unstructured":"Travers, J. & Rothenberg, M. E. Eosinophils in mucosal immune responses. Mucosal Immunol. 8, 464\u2013475 (2015).","journal-title":"Mucosal Immunol."},{"key":"599_CR57","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.jaci.2012.04.027","volume":"130","author":"DJ Diemert","year":"2012","unstructured":"Diemert, D. J. et al. Generalized urticaria induced by the Na-ASP-2 hookworm vaccine: implications for the development of vaccines against helminths. J. Allergy Clin. Immunol. 130, 169\u2013176.e6 (2012).","journal-title":"J. Allergy Clin. Immunol."},{"key":"599_CR58","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/j.1365-3024.2005.00764.x","volume":"27","author":"JP Hewitson","year":"2005","unstructured":"Hewitson, J. P., Hamblin, P. A. & Mountford, A. P. Immunity induced by the radiation-attenuated schistosome vaccine. Parasite Immunol. 27, 271\u2013280 (2005).","journal-title":"Parasite Immunol."},{"key":"599_CR59","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1128\/CMR.00046-07","volume":"21","author":"DP McManus","year":"2008","unstructured":"McManus, D. P. & Loukas, A. Current status of vaccines for schistosomiasis. Clin. Microbiol. Rev. 21, 225\u2013242 (2008).","journal-title":"Clin. Microbiol. Rev."},{"key":"599_CR60","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1590\/S0100-879X1998000100022","volume":"31","author":"RA Wilson","year":"1998","unstructured":"Wilson, R. A. Interferon gamma is a key cytokine in lung phase immunity to schistosomes but what is its precise role? Braz. J. Med. Biol. Res. 31, 157\u2013161 (1998).","journal-title":"Braz. J. Med. Biol. Res."},{"key":"599_CR61","doi-asserted-by":"publisher","first-page":"345","DOI":"10.4049\/jimmunol.162.1.345","volume":"162","author":"D Jankovic","year":"1999","unstructured":"Jankovic, D. et al. Optimal vaccination against Schistosoma mansoni requires the induction of both B cell- and IFN-gamma-dependent effector mechanisms. J. Immunol. 162, 345\u2013351 (1999).","journal-title":"J. Immunol."},{"key":"599_CR62","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1007\/s000180050400","volume":"55","author":"L Adorini","year":"1999","unstructured":"Adorini, L. Interleukin-12, a key cytokine in Th1-mediated autoimmune diseases. Cell. Mol. Life Sci. 55, 1610\u20131625 (1999).","journal-title":"Cell. Mol. Life Sci."},{"key":"599_CR63","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.pt.2009.05.011","volume":"25","author":"RA Wilson","year":"2009","unstructured":"Wilson, R. A. & Coulson, P. S. Immune effector mechanisms against schistosomiasis: looking for a chink in the parasite\u2019s armour. Trends Parasitol. 25, 423 (2009).","journal-title":"Trends Parasitol."},{"key":"599_CR64","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.4049\/jimmunol.140.9.3033","volume":"140","author":"GR Harriman","year":"1988","unstructured":"Harriman, G. R., Kunimoto, D. Y., Elliott, J. F., Paetkau, V. & Strober, W. The role of IL-5 in IgA B cell differentiation. J. Immunol. 140, 3033\u20133039 (1988).","journal-title":"J. Immunol."},{"key":"599_CR65","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1002\/eji.1830190602","volume":"19","author":"S Schoenbeck","year":"1989","unstructured":"Schoenbeck, S., Mckenzie, D. T. & Kagnoff, M. F. Interleukin 5 is a differentiation factor for IgA B cells. Eur. J. Immunol. 19, 965\u2013969 (1989).","journal-title":"Eur. J. Immunol."},{"key":"599_CR66","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1046\/j.1365-2567.1998.00512.x","volume":"94","author":"S Bao","year":"1998","unstructured":"Bao, S. et al. Intestinal IgA plasma cells of the B1 lineage are IL-5 dependent. Immunology 94, 181\u2013188 (1998).","journal-title":"Immunology"},{"key":"599_CR67","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1645\/GE-3186.1","volume":"99","author":"R El Ridi","year":"2013","unstructured":"El Ridi, R. & Tallima, H. Vaccine-induced protection against murine schistosomiasis mansoni with larval excretory-secretory antigens and papain or type-2 cytokines. J. Parasitol. 99, 194\u2013202 (2013).","journal-title":"J. Parasitol."},{"key":"599_CR68","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1093\/infdis\/jiu031","volume":"209","author":"S Karmakar","year":"2014","unstructured":"Karmakar, S. et al. Use of an Sm-p80-Based therapeutic vaccine to kill established adult schistosome parasites in chronically infected baboons. J. Infect. Dis. 209, 1929\u20131940 (2014).","journal-title":"J. Infect. Dis."},{"key":"599_CR69","doi-asserted-by":"publisher","first-page":"3652","DOI":"10.1073\/pnas.91.9.3652","volume":"91","author":"MW Carr","year":"1994","unstructured":"Carr, M. W., Roth, S. J., Luther, E., Rose, S. S. & Springer, T. A. Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. Proc. Natl Acad. Sci. USA 91, 3652\u20133656 (1994).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"599_CR70","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1053\/gast.1996.v110.pm8964413","volume":"110","author":"Y Xu","year":"1996","unstructured":"Xu, Y., Rojkind, M. & Czaja, M. J. Regulation of monocyte chemoattractant protein 1 by cytokines and oxygen free radicals in rat hepatic fat-storing cells. Gastroenterology 110, 1870\u20131877 (1996).","journal-title":"Gastroenterology"},{"key":"599_CR71","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1586\/14760584.2016.1131127","volume":"15","author":"AJ Molehin","year":"2016","unstructured":"Molehin, A. J. et al. Development of a schistosomiasis vaccine. Expert Rev. Vaccines 15, 619 (2016).","journal-title":"Expert Rev. Vaccines"},{"key":"599_CR72","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-020-0621-y","volume":"27","author":"AJ Molehin","year":"2020","unstructured":"Molehin, A. J. Schistosomiasis vaccine development: update on human clinical trials. J. Biomed. Sci. 27, 28 (2020).","journal-title":"J. Biomed. Sci."},{"key":"599_CR73","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/nm1430","volume":"12","author":"MH Tran","year":"2006","unstructured":"Tran, M. H. et al. Tetraspanins on the surface of Schistosoma mansoni are protective antigens against schistosomiasis. Nat. Med. 12, 835\u2013840 (2006).","journal-title":"Nat. Med."},{"key":"599_CR74","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1073\/pnas.93.1.269","volume":"93","author":"M Tendler","year":"1996","unstructured":"Tendler, M. et al. A Schistosoma mansoni fatty acid-binding protein, Sm14, is the potential basis of a dual-purpose anti-helminth vaccine. Proc. Natl Acad. Sci. USA 93, 269 (1996).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"599_CR75","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1016\/j.vaccine.2011.01.093","volume":"29","author":"S Ohtake","year":"2011","unstructured":"Ohtake, S. et al. Room temperature stabilization of oral, live attenuated Salmonella enterica serovar Typhi-vectored vaccines. Vaccine 29, 2761\u20132771 (2011).","journal-title":"Vaccine"},{"key":"599_CR76","doi-asserted-by":"publisher","first-page":"17915","DOI":"10.1073\/pnas.0604054103","volume":"103","author":"MJ Worley","year":"2006","unstructured":"Worley, M. J., Nieman, G. S., Geddes, K. & Heffron, F. Salmonella typhimurium disseminates within its host by manipulating the motility of infected cells. Proc. Natl Acad. Sci. USA 103, 17915\u201317920 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"599_CR77","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/1471-2180-9-170","volume":"9","author":"V Karsten","year":"2009","unstructured":"Karsten, V. et al. msbB deletion confers acute sensitivity to CO2 in Salmonella enterica serovar Typhimurium that can be suppressed by a loss-of-function mutation in zwf. BMC Microbiol. 9, 170 (2009).","journal-title":"BMC Microbiol."},{"key":"599_CR78","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1074\/jbc.271.3.1717","volume":"271","author":"G Lipps","year":"1996","unstructured":"Lipps, G., F\u00fcllkrug, R. & Beck, E. Cathepsin B of Schistosoma mansoni: purification and activation of the recombinant proenzyme secreted by Saccharomyces cerevisiae. J. Biol. Chem. 271, 1717\u20131725 (1996).","journal-title":"J. Biol. Chem."},{"key":"599_CR79","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-017-2626-0","volume":"17","author":"DE Phillips","year":"2017","unstructured":"Phillips, D. E., Dieleman, J. L., Lim, S. S. & Shearer, J. Determinants of effective vaccine coverage in low and middle-income countries: a systematic review and interpretive synthesis. BMC Health Serv. Res. 17, 681 (2017).","journal-title":"BMC Health Serv. Res."},{"key":"599_CR80","doi-asserted-by":"publisher","first-page":"635985","DOI":"10.3389\/fimmu.2021.635985","volume":"12","author":"E Driciru","year":"2021","unstructured":"Driciru, E. et al. Immunological considerations for schistosoma vaccine development: transitioning to endemic settings. Front. Immunol. 12, 635985 (2021).","journal-title":"Front. Immunol."},{"key":"599_CR81","doi-asserted-by":"publisher","first-page":"4145","DOI":"10.1128\/IAI.68.7.4145-4154.2000","volume":"68","author":"CM Dozois","year":"2000","unstructured":"Dozois, C. M. et al. Relationship between the Tsh autotransporter and pathogenicity of avian Escherichia coli and localization and analysis of the tsh genetic region. Infect. Immun. 68, 4145 (2000).","journal-title":"Infect. Immun."},{"key":"599_CR82","doi-asserted-by":"publisher","first-page":"e00089","DOI":"10.1128\/IAI.00089-19","volume":"87","author":"K Winter","year":"2019","unstructured":"Winter, K., Xing, L., Kassardjian, A. & Ward, B. J. Vaccination against clostridium difficile by use of an attenuated salmonella enterica serovar typhimurium vector (YS1646) protects mice from lethal challenge. Infect. Immun. 87, e00089\u201319 (2019).","journal-title":"Infect. Immun."},{"key":"599_CR83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41541-022-00463-3","volume":"7","author":"HE Hendin","year":"2022","unstructured":"Hendin, H. E. et al. Elimination of receptor binding by influenza hemagglutinin improves vaccine-induced immunity. NPJ Vaccines 7, 1\u201313 (2022).","journal-title":"NPJ Vaccines"},{"key":"599_CR84","doi-asserted-by":"publisher","first-page":"19.1.1","DOI":"10.1002\/0471142735.im1901s103","volume":"103","author":"MS Tucker","year":"2013","unstructured":"Tucker, M. S., Karunaratne, L. B., Lewis, F. A., Freitas, T. C. & Liang, Y. S. Schistosomiasis. Curr. Protoc. Immunol. 103, 19.1.1\u201319.1.58 (2013).","journal-title":"Curr. Protoc. Immunol."}],"container-title":["npj Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41541-023-00599-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-023-00599-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-023-00599-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T12:05:41Z","timestamp":1677499541000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41541-023-00599-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,27]]},"references-count":84,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["599"],"URL":"https:\/\/doi.org\/10.1038\/s41541-023-00599-w","relation":{},"ISSN":["2059-0105"],"issn-type":[{"value":"2059-0105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,27]]},"assertion":[{"value":"9 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.S.H., M.N., and B.J.W. are named as inventors on a patent for a YS1646-based <i>S. mansoni<\/i> vaccine held by Aviex Technologies LLC. S.H., L.L., D.J.P., and C.M.D. have no competing interests to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"27"}}